Why Is Blueprint Medicines (BPMC) Down 18.3% Since Last Earnings Report?Zacks Investment Research • 08/31/19
Blueprint Medicines Corp (BPMC) CEO and President Jeffrey W. Albers Sold $1.6 million of SharesGuruFocus • 08/21/19
Blueprint Medicines Corp (BPMC) CEO Jeffrey Albers on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/02/19
Blueprint Medicines: Precision Medicine Pioneer Shines At ASCO, Further Upside AheadSeeking Alpha • 06/11/19
Blueprint Medicines (BPMC) Up 7.3% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/08/19
Blueprint Medicines Corporation (BPMC) CEO Jeff Albers on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/09/19
Blueprint Medicines (BPMC) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/09/19
Earnings Preview: Blueprint Medicines (BPMC) Q1 Earnings Expected to DeclineZacks Investment Research • 04/24/19
Blueprint Medicines (BPMC) Looks Good: Stock Adds 5.7% in SessionZacks Investment Research • 04/01/19